---
DrugClass: "[[Skeletal Muscle, Bone, and Joint Disorder Drugs]]"
SubClass: "[[Bone resorption inhibitors - Non-Bisphosphonates]]"
DrugClassContra: "[[Bone resorption inhibitors - bisphosphonates#Contraindications]]"
DrugClassAdverse: "[[Bone resorption inhibitors - bisphosphonates#Adverse Reactions]]"
SecondaryDrugClass: 
SecondarySubClass: 
BrandName: Prolia, Xgeva
Chapter: "29"
KindleLinkChap: "[Chapter 29](kindle://book?action=open&asin=B09FRF11YJ&location=15248)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles

```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Treatment postmenopausal osteoporosis, bone loss in men w/ osteoporosis, prostate cancer, women with breast cancer
60 mg subcut every 6 months

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Skin rash, immune suppression, high doseâ€” [[osteonecrotic jaw]]
### Interactions

`= this.ChemLink+this.file.name`

